Predict New Therapeutic Drugs for Hepatocellular Carcinoma Based on Gene Mutation and Expression

Abstract excerpt

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is a leading cause of cancer-related death worldwide. However, cure is not possible with currently used therapies, and there is not so much approved targeted therapy for HCC despite numerous attempts and clinical trials. So, it is essential to identify additional therapeutic strategies to block the growth of HCC tumors. We seek to use...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ferroptosis and cancer prognosis
• Share to RNA modifications and cancer
• Share to Ubiquitin and proteasome pathways